Dow Up 0.26% Nasdaq Up 0.18%

Alimera Sciences, Inc. (ALIM)

-NasdaqGM
5.39 Up 0.06(1.13%) 11:51AM EDT - Nasdaq Real Time Price
Prev Close:5.33
Open:5.17
Bid:5.39 x 200
Ask:5.40 x 100
1y Target Est:10.00
Beta:1.74
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:4.80 - 5.52
52wk Range:1.65 - 8.44
Volume:729,393
Avg Vol (3m):233,025
Market Cap:217.89M
P/E (ttm):N/A
EPS (ttm):-1.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALIM

Comparison

Symbol% ChgMkt Cap
ALIMUp 1.13%217.89M
AGNDown 1.04%52.85B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):36.11
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.11
Quarterly EPS Est (Sep-14) :-0.13
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alimera Sciences, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback